REFERENCES
- Manheimer J. S., Lampe G. N. Clinical Transcutaneous Electrical Nerve Stimulation3rd Ed., F. A. Davis. P.A. Davis Company, Philadelphia 1984
- Harvey M., Elliot M. Transcutaneous electrical nerve stimulation (TENS) for pain management during cavity preparation in pediatric patients. ASDC J. Dent. Child. 1995; 62(1)49–51
- Lee K. L., Chung J. M., Willis W. D., Jr. Inhibition of primata spinothalamic tract cells by TENS. J. Neurosurg. 1991; 62(2)276–287
- Van Vugt D. A., Meites J. Influence of endogenous opiates on anterior pituitary function. Fed. Proc. 1980, June; 39: 82533–82538
- Gilman A. G., Goodman L. S., Rall T. W., Murad F. The Pharmacological Basis of Therapeutics8th Ed. Pergamon, New York 1999; 1
- Handa K., Sasaki J., Tanaka H., Kiyonaga A., Matsunaga A., Shindo M., Arakawa K. Effects of captopril on opioid peptides during exercise and quality of life in normal subjects. Am. Heart J. 1991; 122: 1389–1394
- Kitamura K., Akahori K., Yano H., Iwao K., Oka T. Effects of peptidase inhibitors on anti-nociceptive action of dynorphin-(1–8) in rats. Naunyn-Schmiedebergs Arch. Pharmakol. 2000; 361(3)273–278
- Kisara K. Antinociceptive effect produced by intracerebroventricularly administered dynorphin A is potentiated by p-hydroxymercuribenzoate or phosphoramidon in the mouse formalin test. Brain Res. 2001; 891(1–2)274–280
- Taniguchi T., Fan X. T., Kitamura K., Oka T. Effects of peptidase inhibitors on the enkephalin-induced anti-nociception in rats. Jpn. J. Pharmacol. 1998; 78(4)487–492
- Guasti L., Cattaneo R., Daneri A., Bianchi L., Gaudio G., Regazzi M. B., Grandi A. M., Bertolin I. A., Restelli E., Venco A. Endogenous beta-endorphins in hypertension: correlation with 24-hour ambulatory blood pressure. J. Am. Coll. Cardiol. 1996; 28: 1243–1248
- Judd A. M., Hedge G. A. Direct pituitary stimulation of thyrotropin secretion by opioid peptides. Endocrinology 1983; 113(2)706–710
- Tan No K., Taira A., Sakurada T., Inoue M., Sakurada S., Tadano T., Sato T., Sakurada C., Nylander I., Silberring J., Terenius L., Kisara K. Inhibition of dynorphin-converting enzymes prolongs the antinociceptive effect of intrathecally administered dynorphin in the mouse formalin test. Eur. J. Pharmacol. 1996; 314(1–2)61–67
- Hangaard J., Andersen M., Grodum E., Koldjaer O., Hagen C. The effects of endogenous opioids and cortisol on thyreotropin and prolacting secretion in patients with Addison's disease. J. Clin. Endocrinol. Metab. 1999; 84(5)1595–1601
- Neeck G. Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients. Scand. J. Rheumatol. 2000; 29(Suppl. 113)8–12
- Rasheed A., Tareen I. A. Effects of heroin on thyroid function, cortisol and testosterone levels in addicts. Pol. J. Pharmacol. 1995; 47(5)441–444
- Mitsuma T., Hirooka Y., Nogimori T. Effects of immunoneutralization of endogenous opioid peptides on the hypothalamic–pituitary–thyroid axis in rats. Horm. Res. 1993; 39(1–2)77–80
- Koster R., Anderson M., De Beer E. J. Acetic acid for analgesic screening. Fed. Proc. 1959; 18: 412
- Samuels M. H., Kramer P., Wilson D., Sexton G. Effects of naloxone infusions on pulsatile thyrotropin secretion. J. Clin. Endocrinol. Metab. 1994; 48(5)1249–1252
- Agnati L. F., Benfenati F., Cortelli P., D'Alessandro R., Ghisoli E., Zampa G. A. A study on the effects on interaction between naloxone and 2-Br-alpha-ergocriptine or clonidine on luteinizing hormone, follicle-stimulating hormone, prolactin and thyroid-stimulating hormone levels in normal man serum. Neurosci. Lett. 1979; 12(2–3)307–311
- Josko J. Liberation of thyreotropin, thyroxine and triiodothyronine in the controllable and uncontrollable stress and after administration of naloxone in rats. J. Physiol. Pharmacol. 1996; 47(2)303–310